Sheryl Richardson

Sheryl Richardson is an experienced finance professional currently serving as the Chief Financial Officer for Genomic Medicine at Cytiva since April 2020. Previously, Sheryl held various finance leadership roles at GE Healthcare and GE, where responsibilities included financial analysis, corporate audit, and managing long-term service contracts. Sheryl's career began with a FMP graduate scheme at GE Healthcare, focusing on developing future business leaders through rotational assignments. Earlier roles included marketing positions at Capital Support Ltd and Panasonic, alongside initial experience as a receptionist and assistant accountant at Global Invacom Ltd. Sheryl holds a BA (Hons) in Business Studies with Finance from Bournemouth University.